Tanno Masaya, Kuno Atsushi, Ishikawa Satoko, Miki Takayuki, Kouzu Hidemichi, Yano Toshiyuki, Murase Hiromichi, Tobisawa Toshiyuki, Ogasawara Makoto, Horio Yoshiyuki, Miura Tetsuji
From the Departments of Cardiovascular, Renal, and Metabolic Medicine and.
From the Departments of Cardiovascular, Renal, and Metabolic Medicine and Pharmacology, Sapporo Medical University School of Medicine, S1 W16, Chuo-ku, Sapporo 060-8543, Japan.
J Biol Chem. 2014 Oct 17;289(42):29285-96. doi: 10.1074/jbc.M114.563924. Epub 2014 Sep 3.
Glycogen synthase kinase-3β (GSK-3β) is a major positive regulator of the mitochondrial permeability transition pore (mPTP), a principle trigger of cell death, under the condition of oxidative stress. However, the mechanism by which cytosolic GSK-3β translocates to mitochondria, promoting mPTP opening, remains unclear. Here we addressed this issue by analyses of the effect of site-directed mutations in GSK-3β on mitochondrial translocation and protein/protein interactions upon oxidative stress. H9c2 cardiomyoblasts were transfected with GFP-tagged GSK-3β (WT), a mutant GSK-3β insensitive to inhibitory phosphorylation (S9A), or kinase-deficient GSK-3β (K85R). Time lapse observation revealed that WT and S9A translocated from the cytosol to the mitochondria more promptly than did K85R after exposure to oxidative stress. H2O2 increased the density of nine spots on two-dimensional gel electrophoresis of anti-GSK-3β-immunoprecipitates by more than 3-fold. MALDI-TOF/MS analysis revealed that one of the spots contained voltage-dependent anion channel 2 (VDAC2). Knockdown of VDAC2, but not VDAC1 or VDAC3, by siRNA attenuated both the mitochondrial translocation of GSK-3β and mPTP opening under stress conditions. The mitochondrial translocation of GSK-3β was attenuated also when Lys-15, but not Arg-4 or Arg-6, in the N-terminal domain of GSK-3β was replaced with alanine. The oxidative stress-induced mitochondrial translocation of GSK-3β was associated with an increase in cell death, which was suppressed by lithium chloride (LiCl), a GSK-3β inhibitor. These results demonstrate that GSK-3β translocates from the cytosol to mitochondria in a kinase activity- and VDAC2-dependent manner in which an N-terminal domain of GSK-3β may function as a mitochondrial targeting sequence.
糖原合酶激酶-3β(GSK-3β)是线粒体通透性转换孔(mPTP)的主要正向调节因子,在氧化应激条件下,mPTP是细胞死亡的主要触发因素。然而,胞质中的GSK-3β转位至线粒体从而促进mPTP开放的机制仍不清楚。在此,我们通过分析GSK-3β的定点突变对氧化应激下线粒体转位及蛋白质/蛋白质相互作用的影响来解决这一问题。用绿色荧光蛋白标记的GSK-3β(野生型)、对抑制性磷酸化不敏感的突变型GSK-3β(S9A)或激酶缺陷型GSK-3β(K85R)转染H9c2心肌成纤维细胞。延时观察显示,暴露于氧化应激后,野生型和S9A从胞质转位至线粒体的速度比K85R更快。H2O2使抗GSK-3β免疫沉淀的二维凝胶电泳上9个点的密度增加了3倍以上。基质辅助激光解吸电离飞行时间质谱(MALDI-TOF/MS)分析显示,其中一个点含有电压依赖性阴离子通道2(VDAC2)。通过小干扰RNA(siRNA)敲低VDAC2而非VDAC1或VDAC3,可减弱应激条件下GSK-3β的线粒体转位及mPTP开放。当GSK-3β N端结构域中的赖氨酸-15被丙氨酸取代时,而非精氨酸-4或精氨酸-6被取代时,GSK-3β的线粒体转位也会减弱。氧化应激诱导的GSK-3β线粒体转位与细胞死亡增加有关,而GSK-3β抑制剂氯化锂(LiCl)可抑制这种细胞死亡。这些结果表明,GSK-3β以激酶活性和VDAC2依赖性方式从胞质转位至线粒体,其中GSK-3β的N端结构域可能作为线粒体靶向序列发挥作用。